Nakhle Saba, M.D.

04/12/2026

https://www.fmolhs.org/news/fmol-health-our-lady-of-the-lake-cancer-institute-delivers-la-1st-cart-therapy-in-outpatient-setting

Our Lady of Lourdes Health has been serving Acadiana since 1949 and is uniquely capable of being your healthcare partner across your full spectrum of life.

12/28/2025

Navigating Mantle Cell Lymphoma therapy in the new era! OncLive interview with Dr. Michael Wang

Michael Wang, MD, and Nakhle Saba, MD, discuss factors that drive BTK inhibitor selection in second-line mantle cell lymphoma.

11/17/2025

CAR T-cell therapy is changing the future of cancer care. This groundbreaking treatment uses a patient’s own immune cells to recognize and destroy cancer cells, offering new hope where other therapies may have failed.

Dr. Nakhle Saba recently joined Talk 107.3’s Medical Monday with Brian Haldane to discuss how this therapy works, which patients are eligible, and how Our Lady of the Lake Health is advancing access to life-saving treatments like CAR T-cell therapy.

Listen to the full interview: https://bit.ly/49gLjmC

09/17/2025

https://www.fmolhs.org/news/our-lady-of-the-lake-cancer-institute-marks-milestone-in-car-t-therapy

Baton Rouge, LA - Our Lady of the Lake Cancer Institute is proud to announce its participation as the first site in Louisiana for a Phase I clinical trial evaluating allogeneic CAR-T cell therapy. Nakhle Saba, MD serves as the principal investigator for this innovative study involving cellular immunotherapy. Allogeneic CAR-T therapy utilizes donor-derived T cells that are genetically engineered to recognize and target cancer cells. This innovative approach may lead to reduced treatment durations and enhanced patient outcomes.

Our Lady of Lourdes Health has been serving Acadiana since 1949 and is uniquely capable of being your healthcare partner across your full spectrum of life.

08/27/2025

https://youtu.be/SzCiMtV7tsM?si=oSc-NQeOp4uSMlc6
Today’s Advocate meeting with us about our rising program at the Our Lady of the Lake, in blood cancers and cell therapy!

The treatment for blood cancers like leukemia and lymphoma is advancing faster than ever before. In this special broadcast, we sit down with leading experts ...

06/10/2025

https://ascopubs.org/doi/abs/10.1200/JCO.2025.43.16_suppl.e19081

Our poster data presented at ASCO:
Mantle Cell Lymphoma , good news overall:
1- U.S. rates are declining over time.
2- Survival is increasing over time.
3- Dose response relationship between survival and income observed.
4- Survival of Black and API dramatically improved: better access to healthcare and potentially better prognosis.

e19081Background: Mantle Cell Lymphoma (MCL) is a rare subtype of Non-Hodgkin Lymphoma (NHL) that is characterized by cyclin-D1 overexpression. The Surveillance, Epidemiology and End Results (SEER) 22 database includes MCL data collected from 22 US states ...

06/07/2025

https://youtu.be/OPx468RxJho?si=fVBj-_YyEf-d77iy
A real story and some good CLL info!

Disclaimer: This is sponsored content. All opinions and views are of the advertiser and do not reflect the same of WFTS. Advertiser: BeOne Medicines Ltd.A di...

04/21/2025

Nakhle Saba, MD, is redefining cancer care with the curative power of cell therapy for blood cancers. Here, every step forward, every patient’s journey, and ...